Bringing the fundamentals into focus…
Back to Cogent Biosciences, Inc.
How Cogent Biosciences, Inc. stacks up
COGT · against 227 other Healthcare companies of similar size
Profitability
15/ 100
Near the bottom of its peers.
Ranked #204 of 228 · scores higher than 11% of peers
Bars: peers in each 10-point band of the profitability score17 peers with a profitability score of 10–19, including COGT · Click a bar to see the companies
Why profitability scores 15?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 92% of peers. Return on assets: -45.2% vs peer median 1.7%
- a lower return on invested capital: weaker than 88% of peers. Return on invested capital: -53.5% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = COGT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | COGT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 219 reported | -53.5% | 8.2% | 7% | 33% | |
| Operating marginHigher is better · 208 reported | Not reported | 10.7% | — | — | 33% |
| Return on assetsHigher is better · 218 reported | -45.2% | 3.3% | 6% | 33% | |
| Return on equityHigher is better · 213 reported | -109.7% | 7.7% | 6% | Context only | |
| Gross marginHigher is better · 236 reported | 0.0% | 49.6% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around COGT| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 3 | 3.8B USD | 99 | 71 | |
| 5 | 548.2B INR (≈$6.6B) | 98 | 68 | |
| 200 | 3.1B USD | 18 | 39 | |
| 201 | 4.5B USD | 16 | 33 | |
| 201 | 4.0B USD | 16 | 30 | |
| 201 | 6.0B USD | 16 | 32 | |
| 204 | 5.4B USD | 15 | 38 | |
| 205 | 2.7B USD | 14 | 50 | |
| 206 | 3.7B USD | 13 | 31 | |
| 206 | 5.7B USD | 13 | 30 | |
| 206 | 3.9B USD | 13 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score